New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?

被引:0
|
作者
Djordje S. Popovic
Manfredi Rizzo
Edita Stokic
Nikolaos Papanas
机构
[1] Clinical Center of Vojvodina,Clinic for Endocrinology, Diabetes and Metabolic Disorders
[2] University of Novi Sad,Medical Faculty
[3] University of Palermo,Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties of Internal Medicine (Promise), School of Medicine
[4] University Hospital of Alexandroupolis,Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace
来源
Diabetes Therapy | 2021年 / 12卷
关键词
Cardiovascular disease; Diabetes mellitus; Kidney disease; Precision medicine; Prediabetes; Type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
Prediabetes is defined as a condition of abnormal glucose metabolism, characterised by plasma glucose above normal range but not as high as required for the diagnosis of diabetes mellitus (DM). It represents a heterogeneous entity of intermediate glucose metabolism, including impaired fasting glucose, impaired glucose tolerance, and borderline glycated haemoglobin. Prediabetes is being increasingly recognised as an important metabolic state not only predisposing to a higher probability of future progression to DM, but also to an increased risk of different micro- and macrovascular complications. The recently proposed sub-phenotyping of individuals at increased risk of type 2 DM, which distinguishes six different clusters, offers the opportunity for the improvement in screening, prevention, and treatment algorithms. Such progress should also enable more efficient and cost-effective strategies aimed at decreasing the disease burden associated with prediabetes.
引用
收藏
页码:1605 / 1611
页数:6
相关论文
共 50 条
  • [31] Screening of dyslipidemias in subjects at risk of developing type 2 diabetes
    Lounici, A.
    Makour, M.
    Benbelkacem, F.
    Akacem, O.
    Brouri, M.
    DIABETES & METABOLISM, 2008, 34 : A86 - A86
  • [32] Screening of insulin resistance in subjects at risk for type 2 diabetes
    Ghouini, Ahmed
    Rahal, Lotfi
    Djoghlaf, Djamel El Harb
    ACTA PHYSIOLOGICA, 2016, 217 : 109 - 109
  • [33] Iatrogenic hypoglycemia and cardiovascular risk in subjects with type 2 diabetes
    Consoli, Agostino
    Di Fulvio, Patrizia
    GIORNALE ITALIANO DI CARDIOLOGIA, 2012, 13 (12) : 787 - 792
  • [34] Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies
    Malik, M. E.
    Andersson, C. A.
    Blanche, P. B.
    Rasmussen, C. M. R.
    Zareini, B. Z.
    D'Souza, M. D.
    Lamberts, M. L.
    Kristensen, S. L. K.
    Sattar, N. S.
    McMurray, J. M.
    Koeber, L. K.
    Pedersen, C. T. P.
    Gislason, G. G.
    Schou, M. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 152 - 152
  • [35] HDL abnormalities in type 2 diabetes: Clinical implications
    Martagon, Alexandro J.
    Zubiran, Rafael
    Gonzalez-Arellanes, Rogelio
    Praget-Bracamontes, Samantha
    Rivera-Alcantara, J. Adrian
    Aguilar-Salinas, Carlos A.
    ATHEROSCLEROSIS, 2024, 394
  • [36] CLINICAL IMPLICATIONS OF MYOKINES IN TYPE 2 DIABETES MELLITUS
    Nam, J. S.
    Kim, Y. -S.
    Chun, J. Y.
    Kim, M. K.
    Kim, S. H.
    Kang, S. A.
    Park, J. S.
    Ahn, C. W.
    Cha, B. S.
    Kim, K. R.
    Lee, H. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S206 - S206
  • [37] Clinical Implications of Baroreflex Sensitivity in Type 2 Diabetes
    Sakamoto, Masaya
    Matsutani, Daisuke
    Kayama, Yosuke
    INTERNATIONAL HEART JOURNAL, 2019, 60 (02) : 241 - 246
  • [38] Clinical implications and guidelines for CKD in type 2 diabetes
    Zhang, Rong M.
    Persson, Frederik
    McGill, Janet B.
    Rossing, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (03) : 542 - 550
  • [39] Effects of pioglitazone and metformin on β-cell function in nondiabetic subjects at high risk for type 2 diabetes
    Rasouli, Neda
    Kern, Philip A.
    Reece, E. Albert
    Elbein, Steven C.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (01): : E359 - E365
  • [40] Incident myocardial infarction is five fold higher in subjects at high risk for type 2 diabetes
    McKenna, M. P.
    Rowe, M. W.
    Kolberg, J. A.
    Pedersen, O.
    Borch-Johnsen, K.
    Jorgensen, T.
    DIABETOLOGIA, 2010, 53